Doximity (NASDAQ:DOCS – Get Free Report) had its price objective reduced by stock analysts at BTIG Research from $80.00 to $50.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s target price would indicate a potential upside of 50.15% from the stock’s previous close.
DOCS has been the topic of a number of other reports. Raymond James Financial restated a “strong-buy” rating on shares of Doximity in a research note on Monday, December 29th. Barclays assumed coverage on Doximity in a report on Monday, December 8th. They set an “overweight” rating and a $63.00 target price for the company. BMO Capital Markets started coverage on shares of Doximity in a research report on Thursday, November 13th. They set a “market perform” rating and a $55.00 price target on the stock. Wells Fargo & Company upgraded shares of Doximity from an “equal weight” rating to an “overweight” rating and dropped their price objective for the company from $65.00 to $55.00 in a report on Tuesday, January 20th. Finally, KeyCorp reduced their target price on shares of Doximity from $75.00 to $60.00 and set an “overweight” rating on the stock in a report on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $57.47.
View Our Latest Analysis on DOCS
Doximity Price Performance
Doximity (NASDAQ:DOCS – Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm’s revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.45 EPS. Sell-side analysts anticipate that Doximity will post 0.99 EPS for the current fiscal year.
Doximity announced that its Board of Directors has authorized a share buyback plan on Thursday, February 5th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.
Hedge Funds Weigh In On Doximity
Several large investors have recently bought and sold shares of DOCS. Voya Investment Management LLC lifted its holdings in Doximity by 932.8% during the 3rd quarter. Voya Investment Management LLC now owns 1,567,668 shares of the company’s stock worth $114,267,000 after buying an additional 1,415,882 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Doximity by 325,436.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock worth $57,515,000 after purchasing an additional 1,298,492 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Doximity by 53.9% in the second quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock valued at $193,993,000 after purchasing an additional 1,108,162 shares in the last quarter. Capital World Investors increased its stake in Doximity by 25.7% in the third quarter. Capital World Investors now owns 5,381,431 shares of the company’s stock valued at $393,652,000 after purchasing an additional 1,101,848 shares during the last quarter. Finally, Victory Capital Management Inc. raised its holdings in Doximity by 525.3% during the third quarter. Victory Capital Management Inc. now owns 1,096,965 shares of the company’s stock worth $80,243,000 after purchasing an additional 921,533 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.
Doximity News Summary
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: Doximity announced a $500 million share buyback authorization (about 8% of shares outstanding), a signal the board views the stock as undervalued and a potential support for the equity over time. RTT News
- Positive Sentiment: Operational engagement metrics were highlighted as strong: record workflow-product adoption (720,000 users QoQ jump) and 1M+ quarterly active prescribers; early AI products show user traction — positive for long‑term monetization. Business Wire
- Positive Sentiment: Doximity was ranked #1 Best in KLAS Telehealth Video Platform for the fifth consecutive year — supportive for competitive positioning in telehealth workflows. 01net
- Neutral Sentiment: Q3 results: revenue $185.05M (+~10% YoY) and EPS $0.46, both slightly above consensus — beats were modest rather than transformative. Analysts are digging into key metrics for guidance implications. Benzinga
- Neutral Sentiment: A full earnings/management transcript is available for deeper read on product cadence, sales dynamics, and AI roadmap for investors wanting color beyond the headlines. Seeking Alpha transcript
- Negative Sentiment: Management lowered Q4 and FY2026 revenue guidance: Q4 $143.0M–$144.0M vs. consensus ~$150.2M and FY revenue guided slightly below consensus (~$642.5M–$643.5M vs. ~$645.3M). The softer outlook was the primary catalyst for a sharp after‑hours selloff. Business Wire guidance
- Negative Sentiment: Market reaction: shares plunged heavily after the print and guidance miss, reflecting investor sensitivity to near‑term growth deceleration despite buyback and solid engagement metrics. MSN market coverage
Doximity Company Profile
Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”
The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.
Recommended Stories
- Five stocks we like better than Doximity
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
